Emergent BioSolutions Inc. (LON:0IGA)
London
· Delayed Price · Currency is GBP · Price in USD 6.75
-0.26 (-3.67%)
At close: Jul 7, 2025
Emergent BioSolutions Market Cap
Emergent BioSolutions has a market cap or net worth of 274.92 million as of July 9, 2025. Its market cap has increased by 2.78% in one year.
Market Cap
274.92M
Enterprise Value
660.95M
Revenue
747.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.75
Market Cap Chart
Since November 15, 2006, Emergent BioSolutions's market cap has increased from 169.95M to 274.92M, an increase of 61.76%. That is a compound annual growth rate of 2.61%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 160.34B |
| GSK plc | 57.21B |
| Haleon | 33.35B |
| Smith & Nephew | 9.63B |
| ConvaTec Group | 5.35B |
| Hikma Pharmaceuticals | 4.36B |
| HUTCHMED (China) | 1.98B |
| Indivior | 1.41B |